Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of group of thio-matrine derivative and salts thereof to preparation of anti-osteoporosis medicament

A technology of thiomatrine and anti-osteoporosis, which is applied in drug combination, bone disease, and pharmaceutical formula, can solve the problems of unreported effects, achieve high bioavailability, good stability, and reduce loss Effect

Active Publication Date: 2017-06-13
SHANGHAI CHANGHAI HOSPITAL
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no report on the anti-osteoporosis effect of the matrine compounds and their pharmaceutically acceptable salts

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of group of thio-matrine derivative and salts thereof to preparation of anti-osteoporosis medicament
  • Application of group of thio-matrine derivative and salts thereof to preparation of anti-osteoporosis medicament
  • Application of group of thio-matrine derivative and salts thereof to preparation of anti-osteoporosis medicament

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Embodiment 1: Preparation of 15-thiosophocarpine

[0033] 10.0 g (0.04 mol) of sophocarpine and 20.0 g (0.05 mol, purchased from Alfa Company) of sophocarpine were placed in a 500 ml reaction bottle, 200 ml of toluene was added, and the reaction was heated under reflux for 12 hours. After the reaction was completed, the solvent was concentrated under reduced pressure to remove the solvent, and the crude product was passed through a silica gel column with dichloromethane:methanol (25:1) as the eluent to obtain 9.6 g of the product with a yield of 91.2%.

Embodiment 2

[0034] Example 2: Preparation of 13-(N-methyl)-amino-15-thiomatrine (M19)

[0035] 10 g (4 mol) of 18-thiosophocarpine was placed in a 500 ml reaction bottle, 200 ml of methylamino alcohol solution and 10 ml of triethylamine were added, and the reaction was stirred for 12 hours. After the reaction was completed, the solvent was removed by concentration under reduced pressure, and the crude product was passed through a silica gel column with dichloromethane:methanol (20:1) as the eluent to obtain 9.8 g of the product with a yield of 83.5%.

Embodiment 3

[0036] Example 3: Preparation of 13-(N-methyl, N-difluorobenzyl dithioformate)-amino-18-thiomatrine (ZSM-1 in the table)

[0037] Put 240mg (0.8mmol) of 18-thiomatrine (M19) and 160mg (2mmol) of carbon disulfide in a 25ml reaction bottle, add 5ml of acetonitrile, add 374mg (2mmol) of p-fluorobenzyl bromide under stirring, and react at room temperature for 4 hours , After the reaction was completed, the organic solvent was distilled off under reduced pressure, and the crude product was passed through a silica gel column, and the eluent was dichloromethane: acetone (10:1) to obtain 354 mg of a white solid, with a yield of 92.5%.

[0038] The H NMR spectrum and mass spectrometry data of the product are:

[0039] 1 H-NMR (300MHz, CDCl 3 )δ7.41–7.29(m,2H),7.09–6.90(m,2H),6.10(s,1H),5.37(dd,J=12.0,3.8Hz,1H),4.49(d,J=14.5Hz ,3H),3.64–2.95(m,6H),2.84(s,2H),2.37–1.13(m,19H).

[0040] 13 C-NMR (75MHz, CDCl 3 )δ163.87,160.60,131.39,131.34,131.09,130.98,115.67,115.38,77.47,77.25,77....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to application of a group of thio-matrine derivative and salts thereof to preparation of an anti-osteoporosis medicament. The structural general formula of the thio-matrine derivative is shown in the description, where X is a sulfur atom, and an R group is selected from a hydrogen atom, an alkyl group, halogen, nitryl and a cyano group. The group of compositions is proven by bioactivity tests to remarkably reduce the bone mass loss of an ovariectomized mouse, represented by increase of the number of bone trabeculae, the bone surface and bone volume ratio, the relative bone volume or bone volume fraction and the number of bone trabecula connections, and remarkably suppress differentiation of RAW264.7 cells and primary monocytes of the mouse to osteoclasts, and thus can be developed into an anti-osteoporosis medicament or used for preparing a reagent for researches on pathological mechanism of osteoporosis and evaluation of the curative effect of the anti-osteoporosis medicament.

Description

technical field [0001] The invention relates to a new application of the compound, in particular to the application of a group of thiomatrine derivatives and their salts in the preparation of anti-osteoporosis drugs. Background technique [0002] Osteoporosis (Osteoporosis, OP) is a bone disease characterized by decreased bone mass, changes in the microstructure of bone tissue, increased bone fragility, decreased bone strength, and easy fracture [Cosman, F., et al., Clinician's Guide to Prevention and Treatment of Osteoporosis, Osteoporos Int. 2014, 25(10), 2359-81.]. Severe osteoporosis can lead to pain, fractures, and disability, and is known as the silent killer. Recent studies have shown that the imbalance between bone resorption and bone formation is the pathophysiological basis of osteoporosis, which is regulated by osteoblasts that promote bone formation and osteoclasts that promote bone resorption [Del Puente, A., et al., Physiopathology of Osteoporosis: From RiskF...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4375A61P19/10
CPCA61K31/4375
Inventor 苏佳灿赵庆杰陈晓胡宏岗智信卓小斌曹烈虎
Owner SHANGHAI CHANGHAI HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com